|
|
|
|
LEADER |
00000cam a22000004a 4500 |
001 |
JSTOR_ocn226068208 |
003 |
OCoLC |
005 |
20231005004200.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
080423s2003 ncua gob 001 0 eng d |
040 |
|
|
|a NDD
|b eng
|e pn
|c NDD
|d OCLCA
|d OCLCQ
|d OL$
|d OCLCO
|d OCLCQ
|d E7B
|d N$T
|d COO
|d YDXCP
|d MHW
|d EBLCP
|d OCLCQ
|d OCLCO
|d CUS
|d OCLCQ
|d OCLCO
|d IOG
|d OCLCF
|d AU@
|d OCLCQ
|d OCLCO
|d BWN
|d OCLCQ
|d SFB
|d OCLCA
|d JSTOR
|d LUN
|d YDX
|d OCLCE
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d DEGRU
|
019 |
|
|
|a 841913977
|a 850220043
|a 1058894700
|a 1086431342
|a 1097102415
|a 1108981556
|a 1125490218
|a 1136321631
|a 1171424404
|a 1172518726
|a 1196173723
|a 1228080695
|
020 |
|
|
|a 9780822386704
|q (electronic bk.)
|
020 |
|
|
|a 0822386704
|q (electronic bk.)
|
020 |
|
|
|z 0822335247
|q (pbk.)
|
020 |
|
|
|z 9780822335245
|q (pbk.)
|
020 |
|
|
|z 082233061X
|q (alk. paper)
|
020 |
|
|
|z 9780822330615
|q (alk. paper)
|
020 |
|
|
|z 0822330733
|q (alk. paper)
|
020 |
|
|
|z 9780822330738
|q (alk. paper)
|
035 |
|
|
|a (OCoLC)226068208
|z (OCoLC)841913977
|z (OCoLC)850220043
|z (OCoLC)1058894700
|z (OCoLC)1086431342
|z (OCoLC)1097102415
|z (OCoLC)1108981556
|z (OCoLC)1125490218
|z (OCoLC)1136321631
|z (OCoLC)1171424404
|z (OCoLC)1172518726
|z (OCoLC)1196173723
|z (OCoLC)1228080695
|
037 |
|
|
|a 22573/ctv111zd9c
|b JSTOR
|
042 |
|
|
|a dlr
|
043 |
|
|
|a n-us---
|
050 |
|
4 |
|a RC341
|b .M593 2003
|
060 |
|
4 |
|a 2003 G-996
|
060 |
|
4 |
|a WM 402
|b M596p 2003
|
072 |
|
7 |
|a MED
|x 105020
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 105000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.8918
|2 22
|
084 |
|
|
|a 44.38
|2 bcl
|
049 |
|
|
|a UAMI
|
100 |
1 |
|
|a Metzl, Jonathan,
|d 1964-
|e author.
|
245 |
1 |
0 |
|a Prozac on the couch :
|b prescribing gender in the era of wonder drugs /
|c Jonathan Michel Metzl.
|
260 |
|
|
|a Durham :
|b Duke University Press,
|c 2003.
|
300 |
|
|
|a 1 online resource (xii, 275 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references (pages 239-257) and index.
|
505 |
0 |
|
|a 1. Introduction: The Freud of Prozac -- 2. The Name of the Father, the Place of the Medication: A Brief History of Psychiatry, 1955-2002 -- 3. Anxiety, the Crisis of Psychoanalysis, and the Miltown Resolution, 1955-60 -- 4. The Gendered Psychodynamics of Pharmaceutical Advertising, 1964-97 -- 5. Prozac and the Pharmacokinetics of Narrative Form, 1994-2002 -- 6. Conclusion.
|
520 |
|
|
|a Jonathan Michel Metzl, a psychiatrist and women's studies scholar, shows that there's a lot of Dr. Freud encapsulated in late-twentieth-century psychotropic medications. Metzl provides a cultural history of psychiatric "wonder drugs" from the 1950's to the early twenty-first century. in tracing a lineage from Miltown to Valium to Prozac, he uncovers the surprising ways that Freudian gender categories and popular gender roles continue to shape understandings of depression and its treatment
|
588 |
0 |
|
|a Print version record.
|
546 |
|
|
|a English.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified]:
|c HathiTrust Digital Library.
|d 2020.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2020.
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
590 |
|
|
|a JSTOR
|b Books at JSTOR All Purchased
|
590 |
|
|
|a JSTOR
|b Books at JSTOR Demand Driven Acquisitions (DDA)
|
650 |
|
0 |
|a Neuropsychiatry.
|
650 |
|
0 |
|a Psychopharmacology.
|
650 |
|
0 |
|a Psychoanalysis.
|
650 |
|
0 |
|a Gender identity.
|
650 |
|
0 |
|a Medicine
|x Mental health.
|
650 |
|
0 |
|a Social psychology.
|
650 |
|
0 |
|a Industries.
|
650 |
|
0 |
|a Propylamine.
|
650 |
|
0 |
|a Marketing.
|
650 |
|
0 |
|a Communication.
|
650 |
|
0 |
|a Fluoxetine.
|
650 |
|
0 |
|a Social values.
|
650 |
|
0 |
|a Women.
|
650 |
|
0 |
|a Psychotropic drugs.
|
650 |
|
0 |
|a Sex factors in disease.
|
650 |
|
0 |
|a Pharmaceutical industry.
|
650 |
|
0 |
|a Mental illness.
|
650 |
|
0 |
|a Medical personnel.
|
650 |
|
0 |
|a Amines.
|
650 |
|
0 |
|a Public health.
|
650 |
|
0 |
|a Commerce.
|
650 |
|
0 |
|a Organic compounds.
|
650 |
|
0 |
|a Medical care.
|
650 |
|
0 |
|a Psychology.
|
650 |
|
0 |
|a Misinformation.
|
650 |
|
2 |
|a Psychology, Social
|
650 |
|
2 |
|a Persons
|
650 |
|
2 |
|a Behavioral Sciences
|
650 |
|
2 |
|a Medicine
|
650 |
|
2 |
|a Epidemiologic Factors
|
650 |
|
2 |
|a Psychiatry and Psychology
|
650 |
|
2 |
|a Industry
|
650 |
|
2 |
|a Propylamines
|
650 |
|
2 |
|a Central Nervous System Agents
|
650 |
|
2 |
|a Marketing
|
650 |
|
2 |
|a Communication
|
650 |
|
2 |
|a Fluoxetine
|
650 |
|
2 |
|a Social Values
|
650 |
|
2 |
|a Women
|
650 |
|
2 |
|a Psychiatry
|
650 |
|
2 |
|a Advertising
|
650 |
|
2 |
|a Psychotropic Drugs
|
650 |
|
2 |
|a Sex Factors
|
650 |
|
2 |
|a Drug Industry
|
650 |
|
2 |
|a Mental Disorders
|
650 |
|
2 |
|a Health Occupations
|
650 |
|
2 |
|a Quality of Health Care
|
650 |
|
2 |
|a Amines
|
650 |
|
2 |
|a Behavior and Behavior Mechanisms
|
650 |
|
2 |
|a Therapeutic Uses
|
650 |
|
2 |
|a Named Groups
|
650 |
|
2 |
|a Public Health
|
650 |
|
2 |
|a Information Science
|
650 |
|
2 |
|a Behavioral Disciplines and Activities
|
650 |
|
2 |
|a Commerce
|
650 |
|
2 |
|a Technology, Industry, and Agriculture
|
650 |
|
2 |
|a Disciplines and Occupations
|
650 |
|
2 |
|a Health Care Quality, Access, and Evaluation
|
650 |
|
2 |
|a Pharmacologic Actions
|
650 |
|
2 |
|a Technology, Industry, Agriculture
|
650 |
|
2 |
|a Environment and Public Health
|
650 |
|
2 |
|a Organic Chemicals
|
650 |
|
2 |
|a Chemical Actions and Uses
|
650 |
|
2 |
|a Delivery of Health Care
|
650 |
|
2 |
|a Chemicals and Drugs
|
650 |
|
2 |
|a Psychopharmacology
|
650 |
|
2 |
|a Gender Identity
|
650 |
|
2 |
|a Patient Care
|
650 |
|
6 |
|a Neuropsychiatrie.
|
650 |
|
6 |
|a Psychopharmacologie.
|
650 |
|
6 |
|a Psychanalyse.
|
650 |
|
6 |
|a Identité de genre.
|
650 |
|
6 |
|a Médecine
|x Santé mentale.
|
650 |
|
6 |
|a Psychologie sociale.
|
650 |
|
6 |
|a Sciences du comportement.
|
650 |
|
6 |
|a Industrie.
|
650 |
|
6 |
|a Propylamine.
|
650 |
|
6 |
|a Médicaments du système nerveux central.
|
650 |
|
6 |
|a Marketing.
|
650 |
|
6 |
|a Communication.
|
650 |
|
6 |
|a Fluoxétine.
|
650 |
|
6 |
|a Valeurs sociales.
|
650 |
|
6 |
|a Femmes.
|
650 |
|
6 |
|a Publicité.
|
650 |
|
6 |
|a Psychotropes.
|
650 |
|
6 |
|a Maladies
|x Facteurs sexuels.
|
650 |
|
6 |
|a Industrie pharmaceutique.
|
650 |
|
6 |
|a Maladies mentales.
|
650 |
|
6 |
|a Personnel médical.
|
650 |
|
6 |
|a Amines.
|
650 |
|
6 |
|a Santé publique.
|
650 |
|
6 |
|a Commerce.
|
650 |
|
6 |
|a Composés organiques.
|
650 |
|
6 |
|a Prestation de soins.
|
650 |
|
6 |
|a Information.
|
650 |
|
6 |
|a Soins médicaux.
|
650 |
|
6 |
|a Mésinformation.
|
650 |
|
7 |
|a psychoanalysis.
|2 aat
|
650 |
|
7 |
|a sex role.
|2 aat
|
650 |
|
7 |
|a social psychology.
|2 aat
|
650 |
|
7 |
|a behavioral sciences.
|2 aat
|
650 |
|
7 |
|a marketing.
|2 aat
|
650 |
|
7 |
|a advertising.
|2 aat
|
650 |
|
7 |
|a mental disorders.
|2 aat
|
650 |
|
7 |
|a public health.
|2 aat
|
650 |
|
7 |
|a organic compounds.
|2 aat
|
650 |
|
7 |
|a women (female humans)
|2 aat
|
650 |
|
7 |
|a MEDICAL
|x Psychiatry
|x Psychopharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Psychiatry
|x General.
|2 bisacsh
|
650 |
|
7 |
|a Women
|2 fast
|
650 |
|
7 |
|a Social values
|2 fast
|
650 |
|
7 |
|a Social psychology
|2 fast
|
650 |
|
7 |
|a Sex factors in disease
|2 fast
|
650 |
|
7 |
|a Public health
|2 fast
|
650 |
|
7 |
|a Psychotropic drugs
|2 fast
|
650 |
|
7 |
|a Propylamine
|2 fast
|
650 |
|
7 |
|a Pharmaceutical industry
|2 fast
|
650 |
|
7 |
|a Organic compounds
|2 fast
|
650 |
|
7 |
|a Mental illness
|2 fast
|
650 |
|
7 |
|a Medical personnel
|2 fast
|
650 |
|
7 |
|a Medical care
|2 fast
|
650 |
|
7 |
|a Marketing
|2 fast
|
650 |
|
7 |
|a Industries
|2 fast
|
650 |
|
7 |
|a Fluoxetine
|2 fast
|
650 |
|
7 |
|a Communication
|2 fast
|
650 |
|
7 |
|a Commerce
|2 fast
|
650 |
|
7 |
|a Amines
|2 fast
|
650 |
|
7 |
|a Gender identity
|2 fast
|
650 |
|
7 |
|a Neuropsychiatry
|2 fast
|
650 |
|
7 |
|a Psychoanalysis
|2 fast
|
650 |
|
7 |
|a Psychopharmacology
|2 fast
|
650 |
|
7 |
|a Psychopharmakotherapie
|2 gnd
|
650 |
|
7 |
|a Geschlechterrolle
|2 gnd
|
650 |
|
7 |
|a Kulturelles System
|2 gnd
|
650 |
|
7 |
|a Psychoanalyse
|2 gnd
|
650 |
1 |
7 |
|a Fluoxetine.
|2 gtt
|
650 |
1 |
7 |
|a Psychofarmaca.
|2 gtt
|
650 |
1 |
7 |
|a Sekseverschillen.
|2 gtt
|
650 |
1 |
7 |
|a Psychoanalyse.
|2 gtt
|
648 |
|
7 |
|a Geschichte 1950-2003.
|2 swd
|
776 |
0 |
8 |
|i Print version:
|a Metzl, Jonathan, 1964-
|t Prozac on the couch.
|d Durham : Duke University Press, ©2003
|z 082233061X
|w (DLC) 2002151959
|w (OCoLC)50851595
|
830 |
|
0 |
|a e-Duke books scholarly collection.
|
856 |
4 |
0 |
|u https://jstor.uam.elogim.com/stable/10.2307/j.ctv111jjbf
|z Texto completo
|
938 |
|
|
|a De Gruyter
|b DEGR
|n 9780822386704
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL1168434
|
938 |
|
|
|a ebrary
|b EBRY
|n ebr10217158
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 599170
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 2956831
|
994 |
|
|
|a 92
|b IZTAP
|